Pegcetacoplan

四川多瑞药业

2026-01-12

Indication:

Treatment of paroxysmal nocturnal hemoglobinuria(PNH)  

Treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).  
Status: under development

Planed Batch Size:5 kg

Prev:

Retatrutide

Next:

Albuvirtide